A new study highlights the independent prognostic importance of intramyocardial hemorrhage (IMH) in managing risk after ST-segment elevation myocardial infarction (STEMI) after researchers associated microvascular injury (MVI) with future adverse outcomes only in patients with a hemorrhagic phenotype (IMH+).